Global E-Clinical Trial Technologies Market to Reach US$1.37 Billion by 2018, According to New Report by Global Industry Analysts, Inc.
Clinical Trial News Wednesday, July 25th, 2012San Jose, California (PRWEB) July 23, 2012
Due to narrowing drug pipelines, expiring patents of popular drugs, and a scarcity of prospective drug launches, the pharmaceutical industry is actively seeking tools that can quicken the drug discovery procedure and boost productivity. Though ongoing research is predicted to help detect additional drug candidates, the rise in clinical resources might not be adequate to match the rising number of candidates that are expected to progress from the pre-clinical to the clinical trials phase. This is expected to promote the employment of electronic clinical trial technologies. E-clinical techniques enable real-time data analysis and can be utilized to make ‘Go-No Go’ decisions much quicker, which in turn cuts down cost and optimizes drug development process. In addition, the enhanced ability to validate data in real time assists in reduction of time-consuming checks, which in turn translates to increased revenues due to timely introduction of pharmaceuticals into the market. Many players in the market are therefore adopting technology solutions to enable them reduce project times, control in-house R&D costs, expand capacities, enhance quality of clinical data, as well as deliver differentiated services to clients. Read more
